Beneficial effect of fluoxetine in a case of sporadic hyperekplexia

Gianpietro Sechi, Stefano Sotgiu, Maria P. Valenti, Maria G. Pitzolu, Paolo Peterlongo, Lidia Larizza, Giulio Rosati

Research output: Contribution to journalArticle

Abstract

We studied a 67-year-old woman with a sporadic form of hyperekplexia, who experienced 8-10 excessive startle responses to unexpected stimuli per month. Therapy with fluoxetine had a definite beneficial effect. This finding supports the hypothesis that serotonergic mechanisms play a role in this disorder.

Original languageEnglish
Pages (from-to)161-163
Number of pages3
JournalClinical Neuropharmacology
Volume23
Issue number3
DOIs
Publication statusPublished - May 2000

Fingerprint

Startle Reflex
Fluoxetine
Therapeutics
Hyperekplexia

Keywords

  • Fluoxetine
  • Hyperekplexia
  • Serotonergic mechanisms

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Clinical Neurology
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Sechi, G., Sotgiu, S., Valenti, M. P., Pitzolu, M. G., Peterlongo, P., Larizza, L., & Rosati, G. (2000). Beneficial effect of fluoxetine in a case of sporadic hyperekplexia. Clinical Neuropharmacology, 23(3), 161-163. https://doi.org/10.1097/00002826-200005000-00006

Beneficial effect of fluoxetine in a case of sporadic hyperekplexia. / Sechi, Gianpietro; Sotgiu, Stefano; Valenti, Maria P.; Pitzolu, Maria G.; Peterlongo, Paolo; Larizza, Lidia; Rosati, Giulio.

In: Clinical Neuropharmacology, Vol. 23, No. 3, 05.2000, p. 161-163.

Research output: Contribution to journalArticle

Sechi, G, Sotgiu, S, Valenti, MP, Pitzolu, MG, Peterlongo, P, Larizza, L & Rosati, G 2000, 'Beneficial effect of fluoxetine in a case of sporadic hyperekplexia', Clinical Neuropharmacology, vol. 23, no. 3, pp. 161-163. https://doi.org/10.1097/00002826-200005000-00006
Sechi, Gianpietro ; Sotgiu, Stefano ; Valenti, Maria P. ; Pitzolu, Maria G. ; Peterlongo, Paolo ; Larizza, Lidia ; Rosati, Giulio. / Beneficial effect of fluoxetine in a case of sporadic hyperekplexia. In: Clinical Neuropharmacology. 2000 ; Vol. 23, No. 3. pp. 161-163.
@article{172051a2f4e747d9911c562577dc1819,
title = "Beneficial effect of fluoxetine in a case of sporadic hyperekplexia",
abstract = "We studied a 67-year-old woman with a sporadic form of hyperekplexia, who experienced 8-10 excessive startle responses to unexpected stimuli per month. Therapy with fluoxetine had a definite beneficial effect. This finding supports the hypothesis that serotonergic mechanisms play a role in this disorder.",
keywords = "Fluoxetine, Hyperekplexia, Serotonergic mechanisms",
author = "Gianpietro Sechi and Stefano Sotgiu and Valenti, {Maria P.} and Pitzolu, {Maria G.} and Paolo Peterlongo and Lidia Larizza and Giulio Rosati",
year = "2000",
month = "5",
doi = "10.1097/00002826-200005000-00006",
language = "English",
volume = "23",
pages = "161--163",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Beneficial effect of fluoxetine in a case of sporadic hyperekplexia

AU - Sechi, Gianpietro

AU - Sotgiu, Stefano

AU - Valenti, Maria P.

AU - Pitzolu, Maria G.

AU - Peterlongo, Paolo

AU - Larizza, Lidia

AU - Rosati, Giulio

PY - 2000/5

Y1 - 2000/5

N2 - We studied a 67-year-old woman with a sporadic form of hyperekplexia, who experienced 8-10 excessive startle responses to unexpected stimuli per month. Therapy with fluoxetine had a definite beneficial effect. This finding supports the hypothesis that serotonergic mechanisms play a role in this disorder.

AB - We studied a 67-year-old woman with a sporadic form of hyperekplexia, who experienced 8-10 excessive startle responses to unexpected stimuli per month. Therapy with fluoxetine had a definite beneficial effect. This finding supports the hypothesis that serotonergic mechanisms play a role in this disorder.

KW - Fluoxetine

KW - Hyperekplexia

KW - Serotonergic mechanisms

UR - http://www.scopus.com/inward/record.url?scp=0034130236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034130236&partnerID=8YFLogxK

U2 - 10.1097/00002826-200005000-00006

DO - 10.1097/00002826-200005000-00006

M3 - Article

C2 - 10895400

AN - SCOPUS:0034130236

VL - 23

SP - 161

EP - 163

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - 3

ER -